接受抗逆转录病毒治疗者中复发性亚临床结核:发病率、临床病程与结局
南非一项前瞻性研究纳入402例既往治疗过结核的成人HIV/AIDS患者,每季度临床和细菌学筛查、每半年胸片随访36个月,发现48例(11.9%)细菌学确诊的复发性结核,其中亚临床结核17例(35.4%),亚临床结核发病率为0.9/100人年。
要点
- 402例既往结核治疗过的HIV感染者中,复发性结核48例(11.9%),亚临床结核占35.4%。
- 复发性结核总发病率为2.3/100人年,临床结核1.5/100人年,亚临床结核0.9/100人年。
- 亚临床结核中82.4%仅靠结核培养诊断,64.7%接受治疗,35.3%自发缓解。
核心结论
- HIV/AIDS患者中复发性亚临床结核发病率高,凸显高结核-HIV负担地区基于症状的结核筛查不足。
研究设计与样本
- 前瞻性队列研究,纳入402例既往治疗过结核的成人HIV/AIDS患者,来自南非Centre for the AIDS Programme of Research in South Africa TRuTH研究。
- 参与者每季度接受临床和细菌学评估、每半年接受胸片检查,随访36个月;疑似或确诊结核者转诊至国家结核规划。
- 参与者接受HIV服务,包括抗逆转录病毒治疗。
主要发现
- 402例中48例(11.9%)为细菌学确诊的复发性结核,其中亚临床结核17/48(35.4%),临床结核31/48(64.5%)。
- 亚临床、临床和无结核组间年龄、性别和体重指数相似。
- 复发性结核总发病率为2.3/100人年(95%CI 1.7-3.0),临床结核组为1.5/100人年(95%CI 1.1-2.2),亚临床结核组为0.9/100人年(95%CI 0.5-1.4)。
- 亚临床结核组中14/17(82.4%)仅通过结核培养诊断,11/17(64.7%)接受结核治疗,6/17(35.3%)自发缓解。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Undiagnosed asymptomatic subclinical tuberculosis (TB) remains a significant threat to global TB control, accounting for a substantial proportion of cases among people living with human immunodeficiency virus (HIV)/AIDS (PLWHA). We determined incidence, progression, and outcomes of subclinical TB in antiretroviral therapy (ART)-accessing PLWHA with known previous TB in South Africa. METHODS: A total of 402 adult PLWHA previously treated for TB were enrolled in the prospective Centre for the AIDS Programme of Research in South Africa TRuTH (TB Recurrence Upon TB and HIV treatment) Study. Participants were screened for TB with quarterly clinical and bacteriologic evaluation and biannual chest radiographs over 36 months. Those with suspected or confirmed TB were referred to the National TB Programme. Participants received HIV services, including ART. Incidence rate of TB was estimated using Poisson regression and descriptive statistical analyses summarized data. RESULTS: A total of 48 of 402 (11.9%) bacteriologically confirmed incident recurrent TB cases were identified, comprising 17 of 48 (35.4%) subclinical TB cases and 31 of 48 (64.5%) clinical TB cases. Age, sex, and body mass index were similar among subclinical, clinical, and no TB groups. Incidence rates (95% Confidence Interval [CI]) of recurrent TB overall, in clinical and subclinical TB groups were 2.3 (1.7-3.0), 1.5 (1.1-2.2), and 0.9 (0.5-1.4) per 100 person-years, respectively. In the subclinical TB group, 14 of 17 (82.4%) were diagnosed by TB culture only, 11 of 17 (64.7%) received TB treatment, and 6 of 17 (35.3%) resolved TB spontaneously. CONCLUSIONS: High incidence rates of recurrent subclinical TB in PLWHA highlight inadequacies of symptom-based TB screening in high TB-HIV burden settings.
引用
- Naidoo K, Moodley MC, Hassan-Moosa R, et al. Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy-Accessing Participants: Incidence, Clinical Course, and Outcomes. Clin Infect Dis. 2022. PMID: 35247054. doi:10.1093/cid/ciac185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。